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Abstract: In this work, three novel magnetic metal–ceramic nanocomposites were obtained by
thermally treating Fe-exchanged zeolites (either A or X) under reducing atmosphere at relatively mild
temperatures (750–800 ◦C). The so-obtained materials were thoroughly characterized from the point
of view of their physico-chemical properties and, then, used as magnetic adsorbents in the separation
of the target gene factors V and RNASE and of the Staphylococcus aureus bacteria DNA from human
blood. Such results were compared with those obtained by using a top ranking commercial separation
system (namely, SiMAG-N-DNA by Chemicell). The results obtained by using the novel magnetic
adsorbents were similar to (or even better than) those obtained by using the commercial system, both
during manual and automated separations, provided that a proper protocol was adopted. Particularly,
the novel magnetic adsorbents showed high sensitivity during tests performed with small volumes
of blood. Finally, the feasible production of such magnetic adsorbents by an industrial process was
envisaged as well.
Keywords: biological separations; porous metal–ceramic nanocomposites; magnetic nanoparticles;
zeolite precursor; thermal treatment; adsorption
1. Introduction
Separation of biological entities from biological fluids is the mandatory prerequisite of many
biochemical and diagnostic processes [1]. Several methods for biological entity purification have
been developed, so far, spanning from traditional fluid-phase methods, based on a complex series of
precipitation and washing steps, to alternative solid-phase techniques, based on either ionic exchange
in aqueous environment (by means of an anion exchanger) or adsorption on hydrophilic matrices
(typically silica) under chaotropic conditions [2–10]. The scientific and technologic community is
paying increasing attention to the use of magnetic solid adsorbents that can easily be separated from
biological fluids by using an external magnet, the adsorbed species being, then, recovered by a simple
elution step [11,12].
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The most common magnetic materials/systems used in biological separations imply the use of
nanoparticles with an iron oxide core (either magnetite (Fe3O4) or maghemite (γ-Fe2O3), usually)
covered by a porous silica shell; the core is responsible for the magnetic behavior, while the surface
shell adsorbs some targeted biological entities [11–14], as described by a great deal of literature reports
on their preparation and characterization [1,11–24]. However, the use of such systems in the separation
of nucleic acids from biological fluids does not appear free from troubles. In particular, the proper
manufacture of their complicated microstructures is usually attained by laborious, multi-step, and
lengthy techniques (e.g., sol–gel assisted co-precipitation), which require both skillful chemists and
expensive reactants. As further drawbacks, only a few grams of final product can be obtained in a single
batch; some syntheses are poorly reproducible (giving rise to slightly different magnetic adsorbents
that, in turn, require different settings of the used apparatus) and the final product is expensive [20–22].
All the aforementioned aspects are seen as crucial issues, especially by the insiders.
Such considerations explain the growing demand of alternative techniques of production of
magnetic carriers for biological separations. To this end, a patented process, set up by some of us [25,26],
could be used in the manufacture of reliable magnetic adsorbents. In such a process, the employed raw
materials are commercial zeolites (price per kg, some dozens of Euros), the use of which is widespread
in many technological sectors [27,28]. In the process [25,26], zeolites are repeatedly exchanged with
transition metal ions (here, Fe2+) and then subjected to chemical reduction by a thermal treatment at
relatively mild temperature (600–850 ◦C) under reducing atmosphere. Such thermal treatment gives
rise to the reduction of a fraction of the exchanged iron ions to Fe0 species and to the simultaneous
structural collapse of the parent zeolite; the final product is a metal–ceramic nanocomposite, where
nanoparticles of Fe0 are dispersed within a ceramic matrix, which, in turn, still exhibits some irregular
porosity, reminiscent of the parent zeolite matrix, and which mostly consists of amorphous silica
and alumina, along with other Fe-containing phases, i.e., FeOx and Fe silicates, vide infra [29–34].
The same metal–ceramic nanocomposites, which have magnetic properties [29–34], were already
successfully used for a broad range of applications, i.e., in the removal of agrochemicals from water by
adsorption [35,36], as simulants of lunar agglutinates [37], and in the separation of Escherichia coli DNA
from a crude cell lysate [38]. Indeed, the results obtained in [38] appeared particularly interesting for
biomolecule separation, since the produced adsorbents were able to separate Escherichia coli DNA with
a yield and an extraction efficiency that were about two or three times higher than those obtained by
using a commercial system (GenElute Bacterial Genomic DNA kit from Sigma-Aldrich).
The above considerations and results triggered the present study, in which some of the metal–ceramic
nanocomposites produced according to [29–38] were tested for some biological separations that are
usually performed in molecular diagnostic laboratories. In particular, the produced magnetic adsorbents
were used here for the separation of the target gene factors V and RNASE and of the Staphylococcus
aureus bacterium from human blood samples. Indeed, Staphylococcus aureus is one of the most common
and lethal causes of bloodstream infection, sepsis, and sepsis shock, with an incidence that is increasing
also in Europe and in the US; worldwide, sepsis is one of the main causes of urgent hospitalization
and of mortality. For instance, an observational study carried out in a Norwegian county [39] showed
that Staphylococcus aureus bloodstream infection brought a high case fatality rate, especially among
patients with severe sepsis and septic shock and among those with pulmonary or an unknown focus
of infection. During the studied period (1996–2011), no decrease in 30- or 90-day mortality risk was
observed, showing the need for continuous surveillance and of further diagnostic and therapeutic efforts
in order to fight such a serious disease. The availability of rapid and affordable detection methods [40]
of bacteria and of their metabolites also affects the therapeutic efficiency. Indeed, beyond clinical
parameters, sepsis is a serious disease for which the diagnosis is usually carried out by searching the
pathogen by culture method (currently, the gold standard method), which responds only after 24–72 h
or even longer time. The culture method is the gold standard only when it is positive, whereas the
method gives a negative response with patients under antibiotic therapy, since bacterial growth is
inhibited. Instead, diagnosis can be obtained within hours of sampling by real-time PCR (polymerase
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chain reaction), a quantitative technique for rapid microbiological diagnosis. This means the possibility
of starting quickly a targeted antibiotic therapy for the found microorganism(s). Furthermore, real-time
PCR sensitivity is fundamental from the diagnostic point of view; the higher the sensitivity, the higher
the ability to “catch” low concentrations of pathogens in blood.
In this work, the same separations were also performed by using one of the best performing
commercial separation systems, i.e., SiMAG-N-DNA produced by Chemicell, hereafter referred to as
Chemicell NPs (N-DNA Particles). The latter is a magnetic fluid/ferrofluid, i.e., an aqueous colloidal
dispersion of superparamagnetic particles with a silica shell and a maghemite core, able to guarantee
a sufficient response to the applied magnetic field, simultaneously having almost zero remanence,
an important parameter in magnetic separations, because the lower the remanence, the better the
particle dispersibility after switching off the external magnetic field [20]. Such magnetic properties
allow use of the system in automated separations, for instance.
The whole set of the reported experiments allowed evaluation of the performance of the proposed
adsorbents for the separation of biological entities as well as comparison of their performance to that
of the top ranking commercial system.
2. Results and Discussion
2.1. Physico-Chemical Characterization of the Magnetic Adsorbents
Table 1 reports some details about preparation of the three magnetic adsorbents that are object of
this study.
According to chemical analysis, the Fe-A zeolite contained 4.51 meq g−1 Fe2+ and 0.58 meq g−1
Na+, and the Fe-X zeolite contained 3.54 meq g−1 Fe2+ and 1.15 meq g−1 Na+. The calculated cation
equivalent fractions (as calculated by using the chemical analysis data) were xFe = 0.89 and xNa = 0.11
(Fe-A), and xFe = 0.75 and xNa = 0.25 (Fe-X). The iron content of the two Fe-exchanged zeolites was
used to calculate the wt.% Fe in the final sample, which, by assuming fully dehydrated materials, were
16.9 wt.% for both FeA750C2h and FeA800C0min magnetic adsorbents and 13.1 wt.% for FeX750C2h.
Seemingly, the wt.% Fe were correlated to the (lower) cation exchange capacity of Na-X zeolite with
respect to Na-A and, accordingly, the parent zeolites were subjected to a different number of exchanges,
as reported in the Materials and Methods section.
Table 1. Parent Fe-exchanged zeolite, temperature, length of the reduction treatment, and name of the
obtained sample.
Zeolite Temperature Length Sample
Fe-A 750 ◦C 2 h FeA750C2h
Fe-A 800 ◦C 0 min FeA800C0min
Fe-X 750 ◦C 2 h FeX750C2h
Figure 1 reports the XRD patterns of the Na-X, Fe-X (a) and Na-A, Fe-A (b) zeolites. Some slight
differences between the XRD patterns of the Na- and Fe-zeolites could be noticed, as seen in both
Figure 1a,b. Particularly, after cation exchange i) some peaks (inset) appeared slightly shifted (arrows);
ii) most of the peaks were reduced in intensity (red curves); and iii) some minor peaks exhibited higher
intensity. Such findings can be reasonably explained by small changes of the zeolite unit cell volume
arising from Fe-exchange and/or the larger X-ray absorption coefficient of Fe2+ ions, as previously
found with Ba2+ exchanged A zeolite [41].
Figure 2 reports the powder XRD patterns of the studied magnetic adsorbents. Reduction of
Fe2+ cations by H2, which leads to H2O production by consumption of framework oxygen, appeared
evident in the XRD patterns of both FeA750C2h and FeX750C2h and, to a minor extent, in that of
FeA800C0min (vide infra). Indeed, a sharp peak at 44.6 2θ and a broad signal centered at about 24 2θ
were observed with the first two patterns. The sharp peak was ascribed to the most intense diffraction
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peak of metallic iron (Fe0 species), arising from the reduction of Fe2+ cations by H2 and less abundant
with the FeA800C0min sample, which underwent a very short thermal treatment, and the broad signal
to the occurrence of an amorphous phase related to the zeolite structure collapse. A small amount
of residual zeolite and of fayalite (Fe2SiO4) were observed in the XRD patterns of FeA750C2h and
FeA800C0min, but not in that of FeX750C2h.
Such XRD results were corroborated by the Rietveld quantitative phase analysis (QPA) results
reported in Table 2. The most relevant result was the amount of (reduced) Fe0, corresponding to 2.6
wt.% Fe (FeA750C2h), 0.3 wt.% Fe (FeA800C0min), and 1.6 wt.% Fe (FeX750C2h). Apparently, the rest
of the iron was contained in the amorphous phase (89.4, 85.8, and 98.4 (wt.%), respectively) resulting
from zeolite structure thermal collapse. Moreover, the presence of small amounts of parent zeolite (1.0
wt.% and 2.4 wt.%) and of fayalite (Fe2SiO4) in both FeA750C2h (7.0 wt.%) and FeA800C0min (11.5
wt.%) explained the corresponding smaller amount of amorphous phase occurring in zeolite A-derived
adsorbents, as compared to the amount of amorphous phase occurring in FeX750C2h. The larger
amount of Fe0 in sample FeA750C2h than in sample FeX750C2h was likely related to a more expedited
iron reduction in the A zeolite structure (rather than in X zeolite), in agreement with the literature [31],
whereas the low Fe0 content in the FeA800C0min sample (only 0.3 wt.%) may be ascribed to the
extremely short reduction time (i.e., 0 min) adopted for its thermal reduction.
Figure 1. Section (a): powder XRD patterns of Na-X and Fe-X zeolites; section (b): powder XRD patterns
of Na-A and Fe-A zeolites.
The values of specific surface area (SBET), total pore volume (Vp), and micropore volume (Vmp) of
the FeA750C2h and FeX750C2h magnetic adsorbents (Table 2) were considerably lower than those of
the parent zeolites, confirming zeolite structure thermal collapse followed by a process of coalescence,
which increased the overall compactness of the final products. Conversely, the FeA800C0min magnetic
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adsorbent exhibited a high value of specific surface area (SBET). Seemingly, the shorter thermal treatment
resulted not only in a lower amount of reduced iron species (Fe0), but also in a lower extent of structural
collapse and coalescence, leading to a material with larger specific surface area (and porosity).
Figure 2. From bottom to top: powder XRD patterns of FeA800C0min, FeA750C2h, and FeX750C2h
samples.
Table 2. Results of QPA as obtained by Rietveld refinement (phase wt.%). Specific surface area (SBET);
total pore volume (Vp); micropore volume (Vmp), as obtained by N2 isotherms at −196 ◦C.
Magnetic
Adsorbent
Parent Zeolite
(wt.%)
Fe0
(wt.%)
Fe2SiO4
(wt.%)
Amorphous
Phase (wt.%)
SBET
(m2 g−1)
Vp
(cm3 g−1)
Vmp
(cm3 g−1)
FeA800C0min 2.4 0.3 11.5 85.8 152 0.42 0.051
FeA750C2h 1.0 2.6 7.0 89.4 9.50 0.055 0.007
FeX750C2h - 1.6 - 98.4 19.03 0.066 0.029
For adsorbents in the liquid phase, the surface area and porosity were not the only important
parameters, as solids have a surface charge in water, which varies with pH; therefore, the ζ-potential
curves of the three magnetic adsorbents are reported in Figure 3. Interestingly, the pH of zero charge
of the FeA7502h and FeA800C0min was ca. 2.6 and 4.7, respectively, in agreement with the fact that
the thermal treatment had a deep effect also on the surface properties of the materials, which were
positively charged at higher pH values. The pH of zero charge of the FeX7502h material was somehow
intermediate between the other two values. In a previous work [38], however, it was shown that the
negative surface charge of these magnetic adsorbents did not hamper interaction with (negatively
charged) DNA moieties, since, besides electrostatic interactions, van der Waals forces and especially
H-bonds also occurred. Such processes are expected to be even more complex when DNA separation
occurs in human blood.
As a whole, the reported physico-chemical characterization showed that the obtained materials
were mainly amorphous and had a more heterogeneous surface with respect to core–shell particles
with a silica shell (like Chemicell NPs, for instance). Besides amorphous silica, the resulting matrix
embedded the Fe0 NPs and contained also aluminum oxides/hydroxides (deriving from the zeolite
framework collapse) and other Fe-containing phases (FeOx and, in two samples, Fe2SiO4, as detailed
in Table 2).
Figure 4 reports the TEM images of the FeX750C2h, FeA750C2h, and FeA800C0min magnetic
adsorbents. With all the three samples, Fe0 nanoparticles having different sizes were homogeneously
dispersed in a prevailingly amorphous matrix. In previous works [37,38], both the particle size
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distribution and the average particle size were determined by TEM analysis and here, for the sake of
brevity, only the most relevant results are mentioned. In particular, the Fe0 nanoparticles’ average
diameter was 4.4, 6.2, and 6.0 nm in FeX750C2h, FeA750C2h, and FeA800C0min, respectively [37,38].
It must be said that also few larger Fe0 particles, with dimension in the 50–150 nm range, were detected
in all the three samples (not reported), but their number was so small that it did not sensibly alter
the particle size distribution [37,38]. The slightly smaller particle size observed with the FeX750C2h
sample, as compared to the two samples obtained from the Fe-A zeolite, could be due to the parent
zeolite structure, since cation sites in the X zeolite (Si/Al = 2.5) were more diluted (far from each other)
than in the A zeolite, which had a lower Si/Al ratio (Si/Al = 1.0), and, thus, smaller Fe0 nanoparticles
were obtained. Further considerations on the actual relevance of the difference particle size can be
drawn by the magnetization measurements reported in the following paragraph.
Figure 3. ζ-potential curves of FeA750C2h (squares), FeA800C0min (triangles), and FeX750C2h (circles).
Figure 4. Selected TEM micrographs of the FeX750C2h, FeA750C2h, and FeA800C0min magnetic adsorbents.
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2.2. Magnetic Characterization
The magnetic properties of the three adsorbents were magnetically characterized at room
temperature using a vibrating sample magnetometer in the range 0–1.7 × 104 Oe. The equilibrium
magnetization curves in the first quadrant are reported in Figure 5.
Figure 5. Room-temperature magnetization curves in the first quadrant for the three examined samples.
All the examined samples were characterized by the presence of a saturating magnetic component
followed by a linear increase of the magnetization curve at high fields. The magnetic signal turned out
to be considerably lower in the FeA800C-0 sample than in the other two samples. These results were
compatible with the co-presence of magnetic Fe0 nanoparticles and of a fraction of transition-metal
cations still dispersed in the samples; the present results indicated that—in the examined samples—the
total number of magnetic nanoparticles was higher when the annealing temperature was lower and
the reduction time higher, and that a role was also played by the type of starting zeolite. Although it is
not possible to safely infer the effect of annealing temperature and time on the number of magnetic
nanoparticles from just two cases, it is reasonable to assume that the observed behavior reflects a more
general rule, considering that both nucleation and kinetics of the reduction reaction become secondary
effects with increasing the temperature of annealing, being overcome at higher temperature by the
process of coalescence among particles (acting to produce less particles of larger size) and by the
increase of reactivity between metal particles and the matrix (acting to produce, above about 750 ◦C,
iron-rich silicate or iron-rich spinel phases, characterized by a room-temperature magnetic response
entirely different from that of metallic nanoparticles).
The magnetic force on a single micrometric grain of annealed material containing a significant
number of Fe0 nanoparticles was evaluated for each of the three samples considering the overall grain
magnetic moment as resulting from the magnetization of the embedded Fe0 nanoparticles. The force
was evaluated under an applied magnetic field of either 1 or 5 kOe (0.1/0.5 T, vertical dashed lines in
Figure 5) and a magnetic-field gradient of either 1 kOe/cm or 5 kOe/cm (=10/50 T/m, compatible with
the behavior in space of the stray field of a commercial NdFeB bar magnet). For these values of the
applied field, the paramagnetic contribution of magnetic ions was negligible.
Using the pairs of lowest/highest values of B and 5B, the following limiting values of the magnetic
force Fm on a single magnetic grain were obtained: for an average diameter of 7.5 mm (typical of grains
existing in the two annealed samples obtained from A zeolite) [36], Fm,min = 2.8 × 10−12 N; Fm,MAX =
3.1 × 10−11 N (Fe800C0min) and Fm,min = 1.6 × 10−11 N; Fm,MAX = 2.1 × 10−10 N (sample FeA750C2h);
for an average grain diameter of 3.8 mm (typical of the sample obtained from X zeolite) [36], Fm,min =
1.3 × 10−12 N; Fm,MAX = 2.0 × 10−11 N (FeX750C2h). Intermediate values of force were obtained for
intermediate values of both B and 5B.
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The reported values were all well above the typical value of the random forces of thermal origin
acting on the grain at room temperature [42,43], so that the deterministic path of the grain by the effect
of the magnetic field gradient was not disrupted by random thermal fluctuations.
On the other hand, if one assumes a drift velocity of magnetic grains of the order of 1.67 ×
10−4 m s−1 (1 cm per minute, appropriate to magnetophoresis of nanoparticle aggregates or large
grains [44]) the viscous force in a fluid with viscosity comparable to water turned out to be of the order
of 1.1 × 10−11 N in samples Fe800C0min and FeA750C2h, whereas it was lower (of the order of 5.3 ×
10−12 N) for FeX750C2h.
As a consequence, all the examined samples can be effectively exploited for steady state
magnetophoresis and/or magnetically supported separation in a fluid environment, although the use
of a strong magnet is recommended in the case of the sample exhibiting the lowest magnetic signal.
2.3. Separation of Biological Entities
Table 3 (Materials and Methods) summarizes the performed biological separations; a careful
examination of the reported results allowed us to infer some considerations concerning several related
practical, technological, and scientific aspects.
As a whole, all the tested adsorbents (including Chemicell NPs) were very effective towards the
separation of biological entities in actual operative conditions (i.e., those of a molecular diagnostic
laboratory). In many cases, the obtained Ct parameter values (the lower its value, the higher the
amount of biological entity initially separated by the adsorbent and, thus, the more effective the
adsorbent itself, as detailed in the Materials and Methods section) were comparable or better than
those obtained with the benchmark system (Chemicell NPs). This observation confirms the actual
possibility of using the proposed magnetic adsorbents for biological separation.
Concerning the crucial role of the adopted protocol, as mentioned in the Material and Methods
section, Protocol 1 was set up with the purpose of obtaining the best biological separations by using
Chemicell NPs. Indeed, according to the usual classification of magnetic adsorbents [38], Chemicell
NP is a type 2 system (i.e., consisting of nanoparticles with a magnetic core coated by a shell to which
biological entities bind), whereas the proposed magnetic adsorbents are type 3 materials (i.e., consisting
of magnetic nanoparticles dispersed within a heterogeneous and still porous matrix, to which biological
entities bind). Thus, to optimize the performance of so markedly different magnetic adsorbents,
different protocols are required.
The last consideration fairly explains the results of Separations 1, 2, and 3 concerning the gene
target RNASE; when Protocol 1 was used, the here proposed magnetic adsorbent’s performance was
worse (with respect to Chemicell NPs), whereas it increased (i.e., lower Ct values were obtained)
when Protocols 4 and 5 were adopted, i.e., when both i) the adsorbents were dehydrated at a higher
temperature and ii) the elution step was performed at higher temperature than in Protocol 1. Similarly,
with the gene target factor V, better performances of the magnetic adsorbents were obtained by adopting
Protocols 4 and 5 (implying higher temperature of both dehydration and elution than Protocols 1, 2,
and 3). The positive effect of both dehydration and elution temperature is likely related to the material
surface properties; indeed, the here proposed magnetic adsorbents were characterized by a plethora of
surface species (amorphous silica and alumina phases, Fe-containing phases, etc.) and, in the case of
FeA800C0min, also residual microporosity due to incomplete zeolite collapse. The aforementioned
surface species were very heterogeneous in nature and may require higher temperature to remove
adsorbed water. Only by this way, surface active sites can become available for the interaction
with DNA moieties. Identifying the precise type of DNA-surface interaction is not straightforward,
especially in the present case. Indeed, several authors [5,45,46] found that DNA adsorption on silica
(a much simpler material) is related to i) shielded intermolecular electrostatic forces; ii) dehydration
of DNA and silica surface; and iii) intermolecular H bond formation in the DNA-silica contact layer.
Those are likely the types of interactions occurring at the surface of Chemicell NPs, which have a silica
shell, simultaneously acting as adsorbing surface and as shield of the Fe-containing core, which has
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“only” a magnetic (i.e., not adsorbent) role. Whilst the Fe-containing phase in Chemicell NPs is not
accessible to target biomolecules, the here proposed adsorbents had a much more heterogeneous (i.e.,
containing different surface species) and porous exposed surface, which also had macropores that
were accessible to DNA moieties, as shown by confocal microscopy technique in a previous work [38].
Besides the functional groups of hydrated amorphous silica, other different types of adsorbing sites
were likely accessible to target biomolecules, with which DNA moieties could interact through stronger
interactions than mere dispersion forces, implying not only H bonding, but also interactions with
other polar/ionic species (likely, surface uncoordinated Al3+ and Fe3+ ions). These species can strongly
interact with DNA moieties that contain both N atoms and phosphate groups, both able to chelate
iron species, and, therefore, require optimized protocols implying for instance elution at a higher
temperature. On the basis of the previous considerations, however, a thorough comprehension of
the complex interplay occurring between DNA moieties and the surface of the proposed magnetic
adsorbents seems a rather complicated task, so far, given the data available to us. Blood itself is
a very complex matrix, where iron species in hemoglobin may inhibit DNA polymerase. Actually,
other experiments and ad hoc investigations are likely required to unravel the type of DNA-surface
interactions taking place in the studied systems, which could be the topic of a forthcoming study.
To the best of our knowledge, the most important results were obtained in Separation 9, during
which different amounts of human blood (0.1, 1.0, 10.0, 100.0 µL) were tested. Apparently, the lower
the amount of blood used, the higher the Ct value obtained, but at low blood volume (namely, 0.1,
1.0, and 10.0 µL), the proposed magnetic adsorbents performed better than Chemicell NPs, whereas
the contrary occurred by using 100.0 µL of blood. This finding points out the high sensitivity of the
proposed adsorbents, suggesting their application for analysis with extremely low amounts of DNA,
i.e., when a tiny amount of blood was available for the separation.
As far as the Separations 10 and 10bis are considered, it must be pointed out that the bacterial
DNA (100 CFU/mL) was successfully separated both in manual and automated mode, indicating
that the proposed adsorbents could be used in actual separations, due to their magnetic properties.
On the other hand, higher Ct values were obtained with the FeA800C0min sample, notwithstanding
the (optimized) Protocol 4 was adopted. In this respect, it must be pointed out that, for instance, the
bacterial genome is much smaller than the human one (ca. three orders of magnitude) and that the
obtained results could be implemented by finding a proper separation protocol.
A comparison of the overall performance of the three magnetic adsorbents is not straightforward,
although some considerations are possible, looking, for instance, at the separations carried out by
following the (optimized) Protocols 4 and 5; the FeX750C2h and FeA750C2h adsorbents had very similar
behaviors (i.e., close values of Ct), whereas (with exception of the Staphylococcus aureus separations) the
FeA800C0min adsorbent had normally a better performance (i.e., lower Ct values) than the FeA750C2h
adsorbent, likely due to its higher specific surface area and higher point of zero charge, both properties
favoring interaction with (negatively charged) DNA moieties. From this point of view, the results
obtained with the FeA800C0min adsorbent during the Staphylococcus aureus DNA separations (i.e.,
higher Ct values) could be due to a facile interaction with (smaller) DNA moieties, which, being
strongly adsorbed, could not be eluted, with a consequent increase of the corresponding Ct values.
Finally, from a practical point of view, the use of the proposed magnetic adsorbents in both manual
and automated mode (to the same extent of Chemicell NPs) is particularly sound, indicating that the
proposed materials have adsorption and magnetic properties allowing automated procedures, which
are highly desirable, especially in actual laboratories analysis.
3. Material and Methods
3.1. Chemicals and Materials Synthesis
Carlo Erba (city, Italy) reagent grade 4A and 13X zeolites (sodium forms, hereafter labeled as
Na-A and Na-X zeolite, respectively), the respective framework type and chemical formula being
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LTA-Na12Al12Si12O48.27H2O and FAU-Na86Al86Si106O384.264H2O [47]. The cation exchange capacity
of both zeolites was experimentally determined by following recommendations of the “batch exchange
method” [48,49]. The obtained values were very close to the calculated cation exchange capacities,
i.e., 5.48 (Na-A) and 4.73 meq g−1 (Na-X). The preparation procedure of the magnetic adsorbents is
depicted in Scheme 1.
Scheme 1. Scheme (not in scale) of the preparation procedure of the magnetic adsorbents by Fe2+
exchange of either Na-A or Na-X zeolite and successive reducing thermal treatment.
In a typical exchange procedure, a proper amount of Na-zeolite was contacted with a 0.1 M Fe2+
solution, prepared by using 99.5 wt.% FeSO4·7H2O (Aldrich) in ddH2O (double-distilled water; ion
exchange conditions: solid/liquid weight ratio = 1/50 g/g; contact time t = 40 min). Fe2+ exchange was
performed at about 7 ◦C under Ar to prevent Fe2+ oxidation, according to [50]. The solid was, then,
separated from the liquid by filtration and contacted again with a fresh solution. In total, the procedure
was iterated 8 and 5 times with Na-A and Na-X zeolite, respectively, due to their different exchange
capacities [51,52]. The Fe2+ exchanged zeolites (hereafter referred to as Fe-A and Fe-X zeolite) were
washed with ddH2O, dried at 80 ◦C for 24 h, and stored for at least 72 h in a 50% relative humidity
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environment (as obtained by using a saturated Ca(NO3)2 solution); this storage method resulting in
the zeolite water saturation. Then, both the Fe-A and Fe-X zeolite were subjected to various thermal
treatments under reducing atmosphere, obtained by putting the powder in a Pt crucible inside an Al2O3
tubular furnace (inner diameter = 6.9 cm, height = 91 cm) and flowing a 2 vol.% H2 in Ar mixture.
In order to obtain the FeA750C2h and FeX750C2h samples (Table 1), each Fe-exchanged zeolite was
heated up to the target temperature (temperature ramp: 10◦ min−1), kept at this temperature for the
fixed time, and then the furnace was switched off and the sample was left to cool down to room
temperature. In order to obtain the FeA800C0min sample (Table 1), the Fe-A zeolite was heated up to
the fixed temperature (temperature ramp: 10◦ min−1), and as soon as the temperature was reached,
the furnace was switched off and the sample was left to cool down to room temperature.
3.2. Characterization Methods
The contents of both Fe2+ and residual Na+ ions in the exchanged zeolites were determined by
atomic absorption spectrophotometry (AAS, Perkin-Elmer AAnalyst 100 apparatus, Milano, Italy) after
dissolving the solids in a 40 wt.% HF and 14 wt.% HClO4 aqueous solution [53,54].
The X-ray powder diffraction (XRPD) characterization (along with Rietveld quantitative phase
analysis), the calculation of the specific surface area according to the Brunauer–Emmett–Teller (BET)
method (SBET), the determination of total pore volume (Vp) and micropore volume (Vmp), the TEM
(transmission electron microscopy) characterization, and the magnetic characterization of the three
magnetic adsorbents are detailed in [37,38].
The ζ-potential curves in deionized water were obtained by measuring the electrophoretic mobility
as a function of pH at 25 ◦C by means of electrophoretic light scattering (ELS) (Zetasizer Nano-ZS,
ZEN5600, Malvern Instruments, Worcestershire, UK). Suspensions were obtained after 2 min of
sonication with an ultrasonic probe (100 W, 20 kHz, Sonoplus; Bandelin, Berlin, Germany), and pH
was adjusted by adding either 0.1 M HCl or 0.1 M NaOH [55].
3.3. Separation of Biological Entities
Volunteers’ blood samples (from Nurex) were tested; for Staphylococcus aureus separation, bacteria
contamination was performed post-sampling.
Separation of the target gene factors V and RNASE and of the bacterium Staphylococcus aureus from
human blood were performed by using the FeA750C2h, FeA800C0min, and FeX750C0min magnetic
adsorbents and one of the best performing commercial separation system, namely SiMAG-N-DNA
particles, produced by Chemicell, referred to as Chemicell NPs (N-DNA particles). According to the
producer, Chemicell NPs consist of ca. 1µ particles of superparamagnetic maghemite, coated with
a porous silica shell (obtained by precipitation method), with a surface area of ca. 100 m2 g−1 that are
commercialized as vials containing 1 mL of 100 mg/mL aqueous suspension.
The amount of the biological entity separated from the human blood was evaluated by real time
PCR [56,57]. In this method, the amount of DNA originally obtained in the separation is amplified
many times by iterating 30–40 times the following steps:
1. DNA denaturation, during which the two filaments are separated (at temperature > 90 ◦C);
2. Duplication of the separated DNA filaments by proper nucleotides and action of the polymerase
enzyme (at about 50–60 ◦C);
3. Extension of the DNA chain by enzyme polymerase (at about 70–75 ◦C).
Such iteration gives rise to an exponential growth of the amount of the originally separated DNA.
The results of such exponential growth are presented in an amplification curve, which reports the
intensity of the fluorescent signal of a component bound to DNA as a function of the number of cycles
of iteration. The amplification curve starts from a baseline, then grows exponentially and, finally,
attains a plateau. From the curve, the value of the “threshold cycle” (Ct) may be detected. Such value
represents the first cycle of iteration in which the fluorescent signal of the component, bound to DNA,
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becomes evident. Thus, the lower the Ct value recorded in the process, the higher the amount of DNA
originally separated by the adsorbent used, and the better its performance in the separation.
In this work, the biological entities’ separations were performed according to the six protocols
detailed below.
Protocol 1: This protocol, which is a modification of the method described by Boom et al. [3],
proved to be particularly suitable in separations made by using Chemicell NP; 1 mL of chaotropic
salt guanidinium isothiocyanate solution was added to 25 µL Chemicell NP suspension (or one of our
magnetic adsorbents). The obtained suspension was mixed to 50 µL of human blood and kept under
continuous stirring for 10 min.
In this lag of time, the chaotropic salt gives rise to cell lysis and favors interaction between
the biological entity and the surface of the adsorbent. Then, Chemicell NP (or another magnetic
adsorbent) were separated from the solution, by using an external magnet, washed twice with a 70 wt.%
ethanol in water solution, washed once with acetone, and finally dried at 60 ◦C for 10 min (these steps
allowed removal of undesired organic substances). The biological entities adsorbed on the surface
of Chemicell NP (or other magnetic adsorbent) were eluted by adding water at 60 ◦C and keeping it
under continuous stirring for 10 min. The yield of the biological separation was evaluated by real time
PCR, reporting the value of Ct.
As Protocol 1 did not prove to be proper for the magnetic adsorbents under study, the following
other protocols were set up.
Protocol 2: 25 µL of a suspension formed by Chemicell NP (or one of the magnetic adsorbents
studied here) water and guanidinium isothiocyanate (prepared as in Protocol 1) was added to 50 µL of
human blood and kept under continuous stirring for 10 min. Then, Chemicell NPs (or of one of the
other magnetic adsorbents) were separated from the solution by using an external magnet, washed
twice with a 70 wt.% ethanol in water solution, and washed once with acetone (to remove undesired
organic substances). The biological entities adsorbed on the surface of Chemicell NPs (or on one of the
other magnetic adsorbent) were eluted by adding water at 60 ◦C and continuously stirring for 10 min.
The yield of the biological separation was evaluated by real time PCR, reporting the value of Ct.
Protocol 3: 300 mg magnetic adsorbent was suspended in water (from 120 to 150 mg/mL), and
then 1 mL of guanidinium isothiocyanate was added. Afterwards, 50 µL of human blood was added
to the suspension and kept under continuous stirring for 10 min. Then, the magnetic adsorbent was
separated from the solution by using an external magnet, washed twice with a 70 wt.% ethanol in water
solution, washed once with acetone, and finally dried at 60 ◦C for 10 min (to remove undesired organic
substances). The biological entities adsorbed on the surface of the magnetic adsorbent were eluted by
adding water at 60 ◦C and continuously stirring for 10 min. The yield of the biological separation was
evaluated by real time PCR, reporting the value of Ct.
Protocol 4: 300 mg magnetic adsorbent was suspended in water (from 120 to 150 mg/mL) and then
1 mL of guanidinium isothiocyanate was added. Afterwards, 50 µL of human blood was added to
the suspension and kept under continuous stirring for 10 min. Then, the magnetic adsorbent was
separated from the solution by using an external magnet, washed twice with a 70 wt.% ethanol in
water solution, washed once with methanol, and finally dried at 85 ◦C for 10 min (to remove undesired
organic substances). The biological entities adsorbed on the surface of the magnetic adsorbent were
eluted by adding water at 80 ◦C and continuously stirring for 10 min. The yield of the biological
separation was evaluated by real time PCR, reporting the value of Ct.
Protocol 5: 300 mg magnetic adsorbent was suspended in water (from 120 to 150 mg/mL) and then
1 mL of guanidinium isothiocyanate was added. Afterwards, 50 µL of human blood was added to
the suspension and kept under continuous stirring for 10 min. Then, the magnetic adsorbent was
separated from the solution by using an external magnet, washed twice with a 70 wt.% ethanol in water
solution, and washed once with ddH2O. The biological entities adsorbed on the surface of the magnetic
adsorbent were eluted by adding water at 80 ◦C and continuously stirred for 10 min. The yield of the
biological separation was evaluated by real time PCR, reporting the value of Ct.
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Protocol 6: 948 mg magnetic adsorbent was added to 7.5 mL of a solution of both guanidinium
isothiocyanate (8 M) and Na3N (0.01 wt.%) in water. Afterwards, 50 µL of human blood was added
to the suspension and kept under continuous stirring for 10 min. Then, the magnetic adsorbent was
separated from the solution by using an external magnet, washed twice with a 70 wt.% ethanol in
water solution, washed once with methanol, and finally dried at 85 ◦C for 10 min (to remove undesired
organic substances). The biological entities adsorbed on the surface of the magnetic adsorbent were
eluted by adding water at 80 ◦C and continuously stirring for 10 min. The yield of the biological
separation was evaluated by real time PCR, reporting the value of Ct.
All the details of the performed biological separations with indication of separated biological
entity, used magnetic adsorbent, followed protocol, adopted modality, and obtained results (reported
as “threshold cycle”, Ct) are listed in Table 3. Some biological separations were performed manually
by an operator, whereas some other were performed by adopting an automated procedure implying
the use of a robot, as detailed in Table 3. Moreover, some changes to the above protocols were adopted
to investigate the role of the amount of blood used in the biological separations (Separation 9, Table 3),
and in some cases the separation runs were performed more than once (Separation 4, Table 3).
Table 3. Summary of the performed biological separations and obtained results.
SEPARATION 1
Biological Entity Adsorbent Protocol Modality Ct
Gene target RNASE FeA800C0min 1 manual 30
Gene target RNASE FeA750C2h 1 manual 32
Gene target RNASE Chemicell NP 1 manual 25
SEPARATION 2
Biological Entity Adsorbent Protocol Modality Ct
Gene target RNASE FeA750C2h 4 manual 24
Gene target RNASE FeX750C2h 4 manual 23.4
Gene target RNASE Chemicell NP 1 manual 24.7
SEPARATION 3
Biological Entity Adsorbent Protocol Modality Ct
Gene target RNASE FeA750C2h 5 manual 23.5
Gene target RNASE FeX750C2h 5 manual 23
Gene target RNASE Chemicell NP 1 manual 24.7
SEPARATION 4 (repeated 3 times)
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 1 manual 26 27 28
Gene target factor V FeA750C2h 1 manual 33 27.8 31.5
Gene target factor V Chemicell NP 1 manual 26 26 27.4
SEPARATION 5
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 2 manual 27.7
Gene target factor V Chemicell NP 2 manual 26.7
SEPARATION 6
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 3 manual 27
Gene target factor V FeA750C2h 3 manual 28
Gene target factor V Chemicell NP 3 manual 24.9
SEPARATION 7 (repeated 3 times, average value reported)
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 4 manual 25.6
Gene target factor V FeA750C2h 4 manual 25.4
Gene target factor V Chemicell NP 4 manual 26
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Table 3. Cont.
SEPARATION 7bis (repeated 3 times, average value reported)
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 4 manual 23.6
Gene target factor V FeA750C2h 4 manual 24.7
Gene target factor V Chemicell NP 4 manual 24
SEPARATION 8 (repeated 3 times, average value reported)
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 5 manual 27.3
Gene target factor V FeA750C2h 5 manual 28.5
Gene target factor V Chemicell NP 5 manual 25.6
SEPARATION 8bis (repeated 3 times, average value reported)
Biological Entity Adsorbent Protocol Modality Ct
Gene target factor V FeA800C0min 5 manual 24.6
Gene target factor V FeA750C2h 5 manual 23.3
Gene target factor V Chemicell NP 5 manual 24
SEPARATION 9 (performed adding different amounts of blood)
Biological Entity Adsorbent Protocol Modality Ct at Blood Volume (µL)
100.0 10.0 1.0 0.1
Gene target factor V FeA800C0min 4 manual 25.7 28 30.8 34
Gene target factor V FeA750C2h 4 manual 26 26.3 30 35
Gene target factor V Chemicell NP 4 manual 24.1 28.4 32 35.7
SEPARATION 10 (repeated 3 times, average value reported)
Biological Entity Adsorbent Protocol Modality Ct
Staphylococcus aureus FeA800C0min 4 manual 35
Staphylococcus aureus FeA750C2h 4 manual 33.4
Staphylococcus aureus Chemicell NP 4 manual 32.4
SEPARATION 10 bis (repeated 3 times, average value reported)
Biological Entity Adsorbent Protocol Modality Ct
Staphylococcus aureus FeA800C0min 4 automated 35.2
Staphylococcus aureus FeA750C2h 4 automated 33.3
Staphylococcus aureus Chemicell NP 4 automated 33.5
4. Conclusions
A facile two step procedure, based on the ionic exchange of (low cost) commercial zeolites, followed
by thermal treatment under reducing atmosphere, allowed for the production of three magnetic
metal–ceramic nanocomposites that performed as very efficient adsorbents during some biological
separations in real conditions, as those normally encountered in molecular diagnostics laboratories.
With respect to other available systems for biological separations, a point of novelty here lays
in the process by which the magnetic adsorbents are produced. Actually, commercial systems are
obtained by powerful (but sophisticated) synthetic techniques (such as the sol–gel method) that require
expensive precursors, skilled chemists, and multi-step procedures. The magnetic adsorbents proposed
here are, instead, obtained starting from low-cost precursors (i.e., commercial zeolite) by a simple
two-step procedure, i.e., a kind of process that could be scaled up, reducing costs of the adsorbent
materials, by using, for instance, a fluidized bed reactor. With respect to the laboratory furnace used
in this work, such type of reactor could indeed allow a more efficient and intimate contact between
the Fe-exchanged zeolite particles and the reducing gas, leading to a further implementation of the
proposed materials. Moreover, the use of a fluidized bed reactor allows dozens of kilograms of final
product to be produced per batch of reaction, which together with the low cost of raw materials, would
result in an overall low-cost process. Since so far no optimization of the process has been performed,
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there is still room for further improvement to the features of the obtained magnetic adsorbents and,
likely, also their performance towards biological separations.
In particular, among the various keys that are available to tune the process of production of
the magnetic adsorbents, zeolites with a slightly higher Si/Al ratio could be used as raw materials,
allowing us to obtain magnetic adsorbents more similar to silica, a material that allows very good
results in biological separations to be attained. As a whole, however, the materials studied in this
paper showed separation performances mostly comparable and sometimes better than that of the
commercial system adopted as a benchmark, showing very good sensitivity in tests carried out with
extremely small blood volumes. Indeed, blood is a difficult-to-treat matrix, due to the presence of iron
sites in hemoglobin, inhibiting DNA polymerase. The here obtained results point out the fact that the
system proposed here, i.e., the magnetic adsorbents along with optimized protocols for real-time PCR
detection, allows extremely high selectivity finally overcoming the issues of tiny blood volumes and
presence of hemoglobin.
Finally, due to their magnetic behavior, the proposed adsorbents could be employed in both
manual and automatized processes, the latter ones being highly desirable in molecular diagnostic
laboratories, where a large number of analysis have to be carried out, especially in critical conditions,
like during epidemic episodes, for instance.
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